【6/30/2021】CAPA-NoVA Distinguished Chinese American (华裔名人) Project
(Introducer: Xinyi Ma)
李敏求 ( Min Chiu Li )(1919-1980 ) was a Chinese-American oncologist and cancer researcher. He was the first therapeutic scientist to demonstrate that systemic chemotherapy could result in the cure of a widely metastatic malignant disease. His discovery opened the era of medical oncology, which has become a major therapeutic discipline in the management of malignant disease. Dr. Min Chiu Li certainly is remembered in the United States as a pioneer, whose research opened up a new approach to the treatment of cancer.
Dr. Li completed his medical training in China and came to this country in 1947 to study bacteriology and immunology at the Post Graduate School of Medicine of the University of Southern California. Dr. Li began to treat his choriocarcinoma patients with an antifolate chemotherapy drug called methotrexate. Li made several subsequent contributions to cancer research. In 1960, he demonstrated that metastatic testicular cancer could be treated with chemotherapy, and in 1977, he showed that the use of fluorouracil in addition to surgery improved the survival rates of patients suffering from colon cancer. In the 1970s, Li served as Director of Medical Research at New York’s Nassau Hospital and later as Professor of Medicine at Loma Linda University School of Medicine.
In recognition of these important achievements, Dr. Li was awarded the Albert Lasker Medical Research Award in 1972, in addition to his many other awards.
More information about him:
https://clincancerres.aacrjournals.org/content/8/9/2764
https://en.wikipedia.org/wiki/Min_Chiu_Li
【Not only do we live among the stars, the stars live within us! 】
